Zivo BioscienceZIVO -27.08%14 Beneish M-Score is -47.47 as of Jun. 25, 2026. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 831 Biotechnology companies, Zivo Bioscience ranks better than 99.52% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -47.47 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Zivo Bioscience's Beneish M-Score or its related term are showing as below:
ZIVO'
s Beneish M-Score Range Over the Past 10 Years
Min: -87.29 Med: -46.64 Max: -24.88
Current: -47.47
During the past 13 years, the highest Beneish M-Score of Zivo Bioscience was -24.88. The lowest was -87.29. And the median was -46.64.
Zivo Bioscience Beneish M-Score Related Terms
Zivo Bioscience Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Zivo Bioscience's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZIVO vs INAB, LPCN, CTXR: Beneish M-Score Comparison
For the Biotechnology subindustry, Zivo Bioscience's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zivo Bioscience Beneish M-Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Zivo Bioscience's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Zivo Bioscience for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0
+
0.528 * 1.0292
+
0.404 * 0.1918
+
0.892 * 2.6125
+
0.115 * 1
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 0.1762
+
4.679 * -9.667263
-
0.327 * 1.3232
=
-47.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(0 / (0 + 0.022))
/
(0 / (0 + 0.27))
=
0
/
0
=
1
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-8.485 - -0.002
-
-3.079)
/
0.559
=
-9.667263
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Zivo Bioscience has a M-score of -47.47 suggests that the company is unlikely to be a manipulator.
Zivo Bioscience (ZIVO) has a Beneish M-Score of -47.47 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zivo Bioscience and its competitors. According to the industry distribution chart, Zivo Bioscience ranks #4 out of 831 companies in the Biotechnology industry, placing it in the top 0.5%.
Is Zivo Bioscience's Beneish M-Score too high?
Zivo Bioscience's current Beneish M-Score is -47.47. Based on the distribution chart, Zivo Bioscience ranks #4 out of 831 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Beneish M-Score compare to INAB and LPCN?
According to the Biotechnology industry distribution chart, Zivo Bioscience ranks #4 out of 831 companies for Beneish M-Score. This places Zivo Bioscience in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current Beneish M-Score is -47.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Beneish M-Score of -47.47. The current Beneish M-Score is -47.47. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Beneish M-Score is -47.47 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
14GF Score
Get the complete analysis for ZIVO
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZIVO has been successfully added to your 
